You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Suppliers and packagers for PROMETHAZINE HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE


✉ Email this page to a colleague

« Back to Dashboard


PROMETHAZINE HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Amneal Pharms PROMETHAZINE HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride SYRUP;ORAL 200963 ANDA Amneal Pharmaceuticals LLC 65162-694-86 118 mL in 1 BOTTLE (65162-694-86) 2013-11-01
Amneal Pharms PROMETHAZINE HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride SYRUP;ORAL 200963 ANDA Amneal Pharmaceuticals LLC 65162-694-90 473 mL in 1 BOTTLE (65162-694-90) 2013-11-01
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drugs: PROMETHAZINE HYDROCHLORIDE and PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE

Last updated: July 28, 2025


Introduction

Navigating the complex supply chain of active pharmaceutical ingredients (APIs) is vital for stakeholders involved in manufacturing, distribution, and procurement of prescription medicines. The drugs Promethazine Hydrochloride and Phenylephrine Hydrochloride with Codeine Phosphate are widely used for their sedative, antihistamine, and cough suppressant properties, respectively. Their procurement hinges on identifying reliable suppliers capable of meeting regulatory standards, optimizing costs, and ensuring consistent quality.


1. Overview of Promethazine Hydrochloride and Phenylephrine Hydrochloride with Codeine Phosphate

Promethazine Hydrochloride serves primarily as an antihistamine for allergy relief, antiemetic, and sedative purposes. Its broad therapeutic uses necessitate a stable supply chain from multiple producers to prevent shortages.

Phenylephrine Hydrochloride with Codeine Phosphate combination is commonly available as a cough syrup or oral solution, offering rapid symptomatic relief. Due to the inclusion of codeine, a controlled substance, suppliers must adhere to stringent regulatory controls.


2. Global Manufacturing and Major Supplier Landscape

Promethazine Hydrochloride

The global manufacturing footprint includes leading API producers in countries such as India, China, and Italy. Notably:

  • Zhejiang Hisun Pharmaceutical Co., Ltd. (China): A prominent manufacturer offering high-quality Promethazine Hydrochloride as part of its extensive API portfolio.

  • Aarti Industries Ltd. (India): Provides a robust supply of Promethazine Hydrochloride, with facilities meeting cGMP standards.

  • Kinotech (India): Specializes in fine chemicals and APIs, including Promethazine Hydrochloride, with export capabilities to North America and Europe.

Phenylephrine Hydrochloride with Codeine Phosphate

Given the controlled status of codeine, suppliers generally APIs separately for phenylephrine and codeine, with formulations ensuring compliance with local regulations:

  • Sun Pharmaceutical Industries Ltd. (India): Supplies both phenylephrine and codeine APIs, with extensive regulatory compliance for controlled substances.

  • Malesci (Italy): Specializes in advanced APIs for controlled substances, providing high-quality codeine phosphate.

  • Siegfried AG (Switzerland): Offers phenylephrine APIs, with robust quality assurance protocols.


3. Regulatory and Compliance Considerations

Suppliers must demonstrate compliance with:

  • Good Manufacturing Practices (GMP): Ensures safety, quality, and efficacy.
  • Controlled Substances Regulations: Particularly for APIs like codeine, which are classified under strict legal frameworks (e.g., DEA regulations in the U.S.).
  • Certifications: ISO certifications, certifications of compliance with pharmacopeial standards (USP, EP, BP).

Note: Some suppliers operate under strict licensing agreements for controlled substances, impacting procurement logistics and costs.


4. Leading Suppliers by Region

Region Major Suppliers Key Features
India Aarti Industries, Sun Pharmaceutical, Lupin Ltd. Cost-effective production, extensive GMP compliance, high export volumes.
China Zhejiang Hisun Pharmaceutical, Zhejiang NHU Co., Ltd. Large-scale manufacturing, competitive pricing, fast regulatory approval cycles.
Europe Siegfried AG, Malesci High regulatory standards, advanced facility certifications, reliability for controlled substances.
North America Cambrex Corporation, Patheon (by Thermo Fisher Scientific) Focus on high-quality APIs, compliance with U.S. FDA standards.

5. Supply Chain Challenges and Risk Mitigation

  • Regulatory Variability: Stringent controls on controlled substances require continuous licensing upkeep.
  • Supply Disruptions: Geopolitical tensions, pandemics, and regulatory changes can impact supply stability.
  • Quality Assurance: Rigorous batch testing, certification, and audits are essential to avoid quality lapses.
  • Price Volatility: Raw material cost fluctuations, currency risks, and regulatory costs can influence pricing.

Mitigation Strategies:

  • Establish multi-source procurement strategies.
  • Develop long-term strategic partnerships with validated suppliers.
  • Implement comprehensive quality management systems.
  • Engage in regular supplier audits and compliance checks.

6. Purchasing Strategies

  • Due Diligence & Validation: Prioritize suppliers with proven compliance records.
  • Volume Negotiation: Leverage economies of scale for cost savings.
  • Inventory Management: Maintain safety stock to buffer against disruptions.
  • Regulatory Liaison: Foster strong communication pathways for rapid response to regulatory updates.

7. Future Supply Trends

  • Growing Demand: Global prevalence of allergy and cough treatments sustains demand.
  • Regulatory Tightening: Increased scrutiny on controlled substances may limit supplier options.
  • Manufacturing Shift: China and India continue expanding capacities; increased automation and quality improvements are evident.
  • Sustainability Initiatives: Suppliers adopting greener practices may become preferred partners.

Key Takeaways

  • The landscape for Promethazine Hydrochloride and Phenylephrine Hydrochloride with Codeine Phosphate is dominated by Asian manufacturers, primarily India and China, with European firms focusing on quality and compliance.
  • Suppliers must comply with international GMP standards and regulations, especially for controlled substances like codeine.
  • Diversification of suppliers minimizes supply chain risks, while strategic partnerships facilitate steady procurement.
  • Regulatory vigilance remains crucial due to the complexities of controlled substance APIs.
  • Supply chain resilience depends on proactive risk mitigation, including inventory buffering and rigorous quality assurance.

FAQs

Q1: What are the key considerations when selecting a supplier for Promethazine Hydrochloride?
A: Quality standards (GMP compliance), regulatory licensing, manufacturing capacity, price competitiveness, and supply reliability.

Q2: Are there any restrictions on sourcing Phenylephrine Hydrochloride with Codeine Phosphate?
A: Yes, due to codeine's status as a controlled substance, sourcing must comply with legal regulations, licensing, and strict monitoring.

Q3: How does geopolitical risk affect API supply chains?
A: Tensions or trade restrictions can impact manufacturing, export licenses, and logistics, potentially causing shortages or price volatility.

Q4: Can synthetic alternatives replace these APIs in formulations?
A: Currently, no direct substitutes fully replicate the pharmacological profiles of Promethazine and phenylephrine with codeine, but ongoing research seeks alternative compounds.

Q5: What role do certification standards play in supplier selection?
A: Certifications such as ISO, GMP, and pharmacopeial approvals ensure compliance, quality, and regulatory acceptance in global markets.


References

[1] U.S. Food & Drug Administration (FDA). Active Pharmaceutical Ingredients.
[2] European Medicines Agency (EMA). Manufacturing & Quality Standards.
[3] Global Industry Analysts. API Manufacturing Trends.
[4] Indian Pharmacopoeia Commission. API Standards.
[5] Drug Enforcement Administration (DEA). Controlled Substances Regulations.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.